Penn Medicine Provider
Hematology, Medical Oncology
Maureen R. Hewitt, MD
5.0
(824)
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Kennett Square
View 2 additional locations
Make an appointmentCall 800-789-7366

About me

Education and training

  • Medical School: Louisiana State University School of Medicine
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

827 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
she took her time with me
May 2025
5.0
5.0
compassionate
May 2025
5.0
5.0
she's amazing
May 2025
5.0
5.0
very knowledgeable and kind

Insurance accepted

My Locations

Learn about location
Learn about location
Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: On the medical staff, but does not have privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Hewitt is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Traynor AM, Hewitt M, Liu G, Flaherty KT, Clark J, Freedman SJ, Leighton AM, Watson PA, Zhao B, O'Dwyer PJ, Wilding G. Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced tumors. , Cancer Chemother Pharmacol: 2010

Hewitt M, Sun W, Haller DG, Mykulowycz K, Tuite C, Rosen M, Caparro M, Giantonio B, Oltoff K. A phase II trial of the Combination of Capecitabine, Oxaliplatin with Bevacuzynab in the Treatment of Advanced Hepatocellular Carcinoma Preliminary Safety Analysis. , Proceedings of the American Society of Clinical Oncology: 2006

Hewitt MR, Haller DG. Adjuvant Therapy for Colon Cancer, Yesterday, Today and Tomorrow , The Article Reviewed Oncology (Williston Park), 20: 2006,473-475

Hewitt MR, Yu K. Treatment Update for Metastatic Pancreatic Cancer , Community Oncology, 3: 2006,28-430

Hewitt MR, Sun W. Oxaliplatin-Associated Hypersensitivity Reactions: Clinical Presentation and Management , Clinical Colorectal Cancer, 2(6): 2006,114-117

Hewitt M, Porter DL, Hummel K, McAlee A, Phillips J, Stadtmauer E, Schuster S, Luger S, Nasta S, Tsai D, Loren A, Perl A, Emerson S, Goldstein SC. Myeloablative vs. Non-Myeloablative Conditioning with Allogeneic Stem Cell Transplantation for High Risk Non-Hodgkin's Lymphoma. Similar Outcomes Despite Differences in Disease Risk , Proceedings of the American Society of Bone Marrow Transplantation: 2005

DeCoster MA, Hewitt MR, Lambeau M, Lascunski M, Bazan NG Modulation of Neuronal Sensitivity to Glutamate by Secretory Phospholipases A2 (SPLA2s) , Proceedings of the Society for Neuroscience: 1997